In this case report we present a patient with displaced donor graft after DSAEK and associated peripheral corneal edema that resolved without any further intervention three months postoperatively.

The central cornea gradually cleared during the first postoperative month while the peripheral superonasal corneal edema in the "uncovered" (by the displaced corneal graft) area remained (Figure 1).

Summer is prime time for outdoor activities. Many people look forward to outdoor time all year long. However, summer can strain your feet, exposing them to inflammation, blisters and other ...

Revuforj (revumenib) is an oral, first-in-class, selective menin inhibitor that is FDA approved for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene ...

Researchers have discovered in a randomized placebo-controlled trial that mifepristone (Korlym) led to a significant ...

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA®</ ...

"This is potentially paradigm-shifting data," Buse previously told MedPage Today, adding that the investigators were "shocked" that the prevalence of hypercortisolism was that hig ...

When something is wrong inside the body, it doesn't always shout, though there might be signs that are easy to miss. The ...

A 69-year-old woman was referred to the retina service for abnormal posterior segment findings.The patient’s medical history ...

Although treatment with high-dose corticosteroids can reduce mast burden and improve symptoms such as pain, congestive heart failure, and cytopenia in patients with MCL, their effects are frequently ...

The approval of GAMMAGARD LIQUID ERC reinforces our commitment to supporting individualized treatment approaches for people with primary immunodeficiency, including a therapeutic option that has the ...